Published in J Infect Dis on November 01, 2011
Forty-five years of Marburg virus research. Viruses (2012) 1.34
Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PLoS One (2013) 1.29
Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell (2015) 1.18
A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity. J Virol (2014) 1.13
African swine fever virus uses macropinocytosis to enter host cells. PLoS Pathog (2012) 1.10
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat Rev Microbiol (2015) 1.07
Camouflage and misdirection: the full-on assault of ebola virus disease. Cell (2014) 1.07
Filovirus entry: a novelty in the viral fusion world. Viruses (2012) 1.03
Cathepsin B & L are not required for ebola virus replication. PLoS Negl Trop Dis (2012) 1.02
An update on the use of antibodies against the filoviruses. Immunotherapy (2013) 1.01
Molecular mechanisms of Ebola virus pathogenesis: focus on cell death. Cell Death Differ (2015) 1.00
Determining the macropinocytic index of cells through a quantitative image-based assay. Nat Protoc (2014) 0.99
Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells. Antiviral Res (2014) 0.94
Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus. Infect Dis Poverty (2014) 0.94
Phosphatidylserine receptors: enhancers of enveloped virus entry and infection. Virology (2014) 0.93
The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge. Antiviral Res (2012) 0.92
Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature (2016) 0.92
A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. J Virol (2013) 0.91
Live cell imaging of viral entry. Curr Opin Virol (2013) 0.90
Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes. J Virol (2012) 0.89
Entry of a novel marine DNA virus, Singapore grouper iridovirus, into host cells occurs via clathrin-mediated endocytosis and macropinocytosis in a pH-dependent manner. J Virol (2014) 0.89
Shedding light on filovirus infection with high-content imaging. Viruses (2012) 0.87
Rab1a regulates sorting of early endocytic vesicles. Am J Physiol Gastrointest Liver Physiol (2014) 0.87
Ebola virus exploits a monocyte differentiation program to promote its entry. J Virol (2013) 0.86
Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus. J Virol (2015) 0.83
African Swine Fever Virus Undergoes Outer Envelope Disruption, Capsid Disassembly and Inner Envelope Fusion before Core Release from Multivesicular Endosomes. PLoS Pathog (2016) 0.82
Ebola virus entry into host cells: identifying therapeutic strategies. Curr Clin Microbiol Rep (2015) 0.82
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses. J Virol (2016) 0.80
AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus. J Virol (2012) 0.80
Dengue-3 Virus Entry into Vero Cells: Role of Clathrin-Mediated Endocytosis in the Outcome of Infection. PLoS One (2015) 0.80
An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions. J Virol (2016) 0.79
Retrovirus entry by endocytosis and cathepsin proteases. Adv Virol (2012) 0.79
Host cell virus entry mediated by Australian bat lyssavirus G envelope glycoprotein occurs through a clathrin-mediated endocytic pathway that requires actin and Rab5. Virol J (2014) 0.79
Endocytic pathways involved in filovirus entry: advances, implications and future directions. Viruses (2012) 0.79
Herpes simplex virus internalization into epithelial cells requires Na+/H+ exchangers and p21-activated kinases but neither clathrin- nor caveolin-mediated endocytosis. J Virol (2014) 0.79
Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells. Plant Cell Rep (2016) 0.78
Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells. Sci Rep (2016) 0.78
A Bispecific Antibody Promotes Aggregation of Ricin Toxin on Cell Surfaces and Alters Dynamics of Toxin Internalization and Trafficking. PLoS One (2016) 0.78
CDC42 Use in Viral Cell Entry Processes by RNA Viruses. Viruses (2015) 0.77
Paramyxovirus Glycoproteins and the Membrane Fusion Process. Curr Clin Microbiol Rep (2016) 0.76
Effective binding of a phosphatidylserine-targeting antibody to Ebola virus infected cells and purified virions. J Immunol Res (2015) 0.76
Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors. Antimicrob Agents Chemother (2016) 0.76
Real-time Imaging of Rabies Virus Entry into Living Vero cells. Sci Rep (2015) 0.76
Fcγ-receptor IIa-mediated Src Signaling Pathway is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection. PLoS Pathog (2016) 0.75
Structure of the Ebola virus glycoprotein spike within the virion envelope at 11 Å resolution. Sci Rep (2017) 0.75
Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles. Antimicrob Agents Chemother (2017) 0.75
Cell Surface THY-1 Contributes to Human Cytomegalovirus Entry via a Macropinocytosis-Like Process. J Virol (2016) 0.75
Cellular factors implicated in filovirus entry. Adv Virol (2013) 0.75
Ebola Virus Delta Peptide is a Viroporin. J Virol (2017) 0.75
Macropinocytic entry of isolated mitochondria in epidermal growth factor-activated human osteosarcoma cells. Sci Rep (2017) 0.75
The lifecycle of the Ebola virus in host cells. Oncotarget (2017) 0.75
Porcine hemagglutinating encephalomyelitis virus enters Neuro-2a cells via clathrin-mediated endocytosis in a Rab5-, cholesterol-, and pH-dependent manner. J Virol (2017) 0.75
On the entry of Semliki forest virus into BHK-21 cells. J Cell Biol (1980) 11.05
Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol (2001) 8.93
The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol (2004) 8.58
Virus entry: open sesame. Cell (2006) 6.33
Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science (1983) 5.23
Exotic emerging viral diseases: progress and challenges. Nat Med (2004) 4.54
Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol (2005) 4.48
C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol (2002) 4.47
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Virus entry by macropinocytosis. Nat Cell Biol (2009) 3.87
Dissecting virus entry via endocytosis. J Gen Virol (2002) 3.74
Shaping cups into phagosomes and macropinosomes. Nat Rev Mol Cell Biol (2008) 3.62
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62
Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol (1996) 3.08
Distinct dynamics of endocytic clathrin-coated pits and coated plaques. PLoS Biol (2009) 2.83
Ebola virus: from discovery to vaccine. Nat Rev Immunol (2003) 2.72
Redundant and distinct functions for dynamin-1 and dynamin-2 isoforms. J Cell Biol (1998) 2.67
Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog (2010) 2.60
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60
Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology (2000) 2.33
Biosynthesis and role of filoviral glycoproteins. J Gen Virol (2001) 1.84
CtBP3/BARS drives membrane fission in dynamin-independent transport pathways. Nat Cell Biol (2005) 1.83
The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol Ther (2009) 1.83
The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol (1995) 1.76
Modulation of Rac localization and function by dynamin. Mol Biol Cell (2003) 1.75
Association of the caveola vesicular system with cellular entry by filoviruses. J Virol (2002) 1.72
Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog (2008) 1.66
Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol (2005) 1.61
Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol (2006) 1.61
Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J Virol (2005) 1.47
Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis (2007) 1.46
In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. J Infect Dis (2007) 1.43
Intracellular objects tracking. Eur J Cell Biol (2007) 1.37
The mechanism of Axl-mediated Ebola virus infection. J Infect Dis (2007) 1.36
Ethylisopropyl-amiloride: a new and highly potent derivative of amiloride for the inhibition of the Na+/H+ exchange system in various cell types. Biochem Biophys Res Commun (1983) 1.32
High-resolution 3D quantitative analysis of caveolar ultrastructure and caveola-cytoskeleton interactions. Traffic (2008) 1.32
Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology (2010) 1.23
Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages? Clin Infect Dis (1998) 1.23
Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina. Gene Ther (2003) 1.07
Regulation of endothelial barrier function during flow-induced conversion to an arterial phenotype. Cardiovasc Res (2007) 0.99
Clathrin couture: fashioning distinctive membrane coats at the cell surface. PLoS Biol (2009) 0.98
Role of actin filaments in endothelial cell-cell adhesion and membrane stability under fluid shear stress. Pflugers Arch (2001) 0.92
Caveolae meet endosomes: a stable relationship? Dev Cell (2004) 0.90
Domain requirements for an endocytosis-independent, isoform-specific function of dynamin-2. Exp Cell Res (2006) 0.90
Non-classical use of clathrin during bacterial infections. J Microsc (2008) 0.88
Genetic manipulation of endothelial cells by viral vectors. Thromb Haemost (2009) 0.88
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med (2005) 6.77
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med (2004) 4.89
Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology (2009) 4.11
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis (2007) 3.51
Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis (2007) 3.47
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet (2006) 3.15
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99
Ebola virus: from discovery to vaccine. Nat Rev Immunol (2003) 2.72
Development of a new vaccine for the prevention of Lassa fever. PLoS Med (2005) 2.71
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates. J Virol (2008) 2.58
Pneumonia from human coronavirus in a macaque model. N Engl J Med (2013) 2.47
Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog (2009) 2.44
Molecular determinants of Ebola virus virulence in mice. PLoS Pathog (2006) 2.44
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus. J Virol (2009) 2.41
Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. Immunity (2012) 2.35
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine (2008) 2.33
SARS--beginning to understand a new virus. Nat Rev Microbiol (2003) 2.30
Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A (2013) 2.29
Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol (2006) 2.24
Pause on avian flu transmission research. Science (2012) 2.24
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis (2007) 2.22
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates. PLoS Pathog (2008) 2.10
Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol (2004) 2.09
The ecology of Ebola virus. Trends Microbiol (2007) 2.08
Disease modeling for Ebola and Marburg viruses. Dis Model Mech (2009) 2.07
Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol (2009) 2.05
Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells. PLoS Biol (2011) 2.02
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med (2013) 1.98
Ebola virus VP40 late domains are not essential for viral replication in cell culture. J Virol (2005) 1.97
DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol (2004) 1.92
Ebola virus: unravelling pathogenesis to combat a deadly disease. Trends Mol Med (2006) 1.92
The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters. PLoS One (2013) 1.88
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J Virol (2006) 1.85
Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. PLoS One (2009) 1.83
Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates. Sci Transl Med (2012) 1.83
Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J Infect Dis (2011) 1.82
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates. Proc Natl Acad Sci U S A (2013) 1.81
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol (2004) 1.80
Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J Virol (2003) 1.78
Prospects for immunisation against Marburg and Ebola viruses. Rev Med Virol (2010) 1.77
Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina. J Biol Chem (2005) 1.77
Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol (2006) 1.76
The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure (2003) 1.75
Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus. J Infect Dis (2011) 1.75
Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J (2004) 1.73
Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis). Comp Med (2010) 1.71
Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol (2002) 1.71
Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice. PLoS One (2008) 1.67
Ebola virus vaccines: an overview of current approaches. Expert Rev Vaccines (2014) 1.67
Framework for leadership and training of Biosafety Level 4 laboratory workers. Emerg Infect Dis (2008) 1.66
VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment. J Virol (2002) 1.63
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. Virology (2005) 1.63
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis (2011) 1.62
Assembly and budding of Ebolavirus. PLoS Pathog (2006) 1.62
Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis (2006) 1.62
Antibody-dependent enhancement of Ebola virus infection. J Virol (2003) 1.62
Progress in filovirus vaccine development: evaluating the potential for clinical use. Expert Rev Vaccines (2011) 1.62
Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol (2005) 1.61
Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol (2006) 1.61
Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies. Clin Vaccine Immunol (2010) 1.59
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59
Phylogeny of the SARS coronavirus. Science (2003) 1.56
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin. Sci Rep (2013) 1.55
Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res (2004) 1.54
Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLoS One (2012) 1.54
The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola. PLoS Negl Trop Dis (2011) 1.53
Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem (2005) 1.53
A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J Virol (2011) 1.53
Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol (2013) 1.52
Reverse genetics for crimean-congo hemorrhagic fever virus. J Virol (2003) 1.52
Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection. PLoS Negl Trop Dis (2012) 1.51
A Syrian golden hamster model recapitulating ebola hemorrhagic fever. J Infect Dis (2012) 1.51
Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J Virol (2006) 1.49
Mass spectrometric characterization of proteins from the SARS virus: a preliminary report. Mol Cell Proteomics (2003) 1.49
Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J Infect Dis (2011) 1.47
Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci Transl Med (2013) 1.47
Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol (2010) 1.47
Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J Virol (2005) 1.47
Multivesicular bodies as a platform for formation of the Marburg virus envelope. J Virol (2004) 1.47
Phosphorylation of VP30 impairs ebola virus transcription. J Biol Chem (2002) 1.47
Generation of biologically contained Ebola viruses. Proc Natl Acad Sci U S A (2008) 1.47
VP24 of Marburg virus influences formation of infectious particles. J Virol (2005) 1.46
Phylogeny of New World arenaviruses based on the complete coding sequences of the small genomic segment identified an evolutionary lineage produced by intrasegmental recombination. Biochem Biophys Res Commun (2002) 1.45
Viral hemorrhagic fever--a vascular disease? Thromb Haemost (2003) 1.43
The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway. J Virol (2004) 1.43